During the past decade, Louisville Cardiology Medical Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Louisville Cardiology Medical Group" #1 sponsor was "Anthera Pharmaceuticals" with 2 trials, followed by "Boston Scientific Corporation" with 1 trials sponsored, "CTI-1, LLC" with 1 trials sponsored, "Lisata Therapeutics, Inc." with 1 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Louisville Cardiology Medical Group" #1 collaborator was "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Louisville Cardiology Medical Group" are "Congestive Heart Failure" (2 trials), "Bradycardia" (1 trials), "Coronary Artery Disease" (1 trials), "Coronary Artery Disease (CAD)" (1 trials) and "ST Segment Elevation Myocardial Infarction" (1 trials). Many other conditions were trialed in "Louisville Cardiology Medical Group" in a lesser frequency.

Most popular intervention types in "Louisville Cardiology Medical Group" are "Drug" (4 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "A-002" (2 trials), "AV Therapy Assessment-B301 investigational device" (1 trials), "NBS10" (1 trials), "Tolvaptan" (1 trials) and "carvedilol controlled release" (1 trials). Other intervention names were less common.

The vast majority of trials in "Louisville Cardiology Medical Group" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Louisville Cardiology Medical Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Louisville Cardiology Medical Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Louisville Cardiology Medical Group, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".